Andere Sprachen Sight Sciences, Inc.

Aktien

A3CU4L

US82657M1053

SGHT

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
5.28 ^USD	+2.72%		+2.92%	+2.33%

10.04.	Sight Sciences, Inc. kündigt die Veröffentlichung einer groß angelegten, realen Migs-Studie an	CI
03.04.	Sight Sciences präsentiert Daten aus Studien zu Technologien für Glaukom und trockenes Auge -- Aktien legen vorbörslich zu	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sight Sciences : SGHT Proxy - Apr'24	26.04.
Sight Sciences to Report First Quarter Financial Results on May 2, 2024	18.04.
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma	10.04.
Sight Sciences, Inc. Announces the Publication of Large-Scale, Real-World Migs Study	10.04.
Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting	03.04.
Sector Update: Health Care Stocks Flat Pre-Bell Wednesday	03.04.
Sight Sciences to Present Data From Studies of Glaucoma, Dry Eye Technologies -- Shares Extend Gains to Premarket	03.04.
Sight Sciences to Present Data From Studies of Glaucoma, Dry Eye Technologies -- Shares Jump After Hours	02.04.
Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting	02.04.
Sight Sciences, Inc. Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT At the 2024 American Society of Cataract and Refractive Surgery Annual Meeting	02.04.
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference	26.03.
Earnings Flash (SGHT) SIGHT SCIENCES Reports Q4 Revenue $18.8M, vs. Street Est of $19.4M	07.03.
Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance	07.03.
Sight Sciences, Inc. Provides Earnings Guidance for the Year 2024	07.03.
Sight Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07.03.
Sight Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07.03.
Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024	22.02.
Sight Sciences Announces European Launch of the Ergo-Series of the OMNI Surgical System at the ESCRS Winter Meeting	15.02.
Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting	14.02.
Sight Sciences, Inc. Announces European Launch of the Ergo-Series of the OMNI Surgical System at the ESCRS Winter Meeting	14.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sight Sciences, Inc.

Aktien

A3CU4L

US82657M1053

SGHT

Andere Sprachen

Filter